Cargando…
Malignant Myeloma in a Patient After Treatment for Osteoporosis with Teriparatide; a Rare Coincidence
A breakthrough in understanding of mechanisms of bone structure regulation has brought about the introduction of the new synthetic recombinant human parathyroid hormone 1–34 (PTH1-34; Teriparatide) in the treatment of osteoporosis. These mechanisms, involving the RANKL, RANK, and osteoprotegerin sys...
Autores principales: | Forslund, Terje, Koski, Anna-Mari, Koistinen, Arvo, Sikiö, Anu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3785327/ https://www.ncbi.nlm.nih.gov/pubmed/24179360 |
Ejemplares similares
-
Teriparatide in the management of osteoporosis
por: Bodenner, Donald, et al.
Publicado: (2007) -
Forty Years Abuse of Baking Soda, Rhabdomyolysis, Glomerulonephritis, Hypertension Leading to Renal Failure: A Case Report
por: Forslund, Terje, et al.
Publicado: (2008) -
Teriparatide – Indications beyond osteoporosis
por: Cheng, Marilyn Lee, et al.
Publicado: (2012) -
Therapy of Osteoporosis in Men with Teriparatide
por: Cusano, Natalie E., et al.
Publicado: (2011) -
Profile of teriparatide in the management of postmenopausal osteoporosis
por: Sikon, Andrea, et al.
Publicado: (2010)